Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang în acțiuni #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Preț acțiune
$3.78
Ultima sincronizare: 2026-03-17
Capitalizare de piață
$276.54M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
45.53%
Țară
CA
Tranzacționează NervGen Pharma Corp. (NGEN)

Categorie

Istoric al prețului acțiunii pentru NervGen Pharma Corp. (NGEN)
Cel mai mare preț de închidere: $3.98 pe 2026-03-01

Cel mai mic preț de închidere: $1.12 pe 2019-03-01
Istoric al prețului acțiunii pentru NervGen Pharma Corp. din 2019 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.20 -10.04%
AU
$748.60 6.90%
CH